An observational study in Osteoporosis, Postmenopausal and Osteoporosis, Steroid Induced, sponsored by 251 Hellenic Air Force & VA General Hospital. Completed at 1 site in Greece. Open to participants aged 35 Years and older. Per ClinicalTrials.gov, last updated 2019-01-10.
Sponsored by 251 Hellenic Air Force & VA General Hospital · Observational
This is a study aiming to investigate a possible correlation between the parameters affecting the physicians' therapeutic choice with the patients' overall adherence to osteoporosis treatment. Secondary end-points include correlation between the parameters affecting the physicians' therapeutic choice and the patients' quality of life as well as the evaluation of the whole osteoporosis treatment approach of orthopedic surgeons in Greece (diagnostic means, use of diagnostic and treatment guidelines, methodology of follow - up).
The study will include 100 orthopedic surgeons from the private sector working in private offices. The selection of this group of physicians resides on the fact that orthopedic surgeons working in private offices hold more than 60% of osteoporosis prescriptions in Greece.
Each physician will fill once a questionnaire regarding the parameters affecting his/her choice of osteoporosis treatment before entering any patient in the study. Following the completion of the questionnaire every physician will recruit up to 10 patients in the study who are eligible for osteoanabolic treatment (teriparatide) according to standard medical practice and the Greek osteoporosis treatment guidelines.
Each patient will receive teriparatide up to 24 months while he/she will fill the Greek EQ5D questionnaire on months: 0,12,24 or at early discontinuation. Adherence to treatment will be evaluated at the same time points as well as on monthly telephone interviews.
Both the adherence to treatment and the possible alteration of patients' quality of life (evaluated through the EQ5D questionnaire) during the study will be correlated with the parameters affecting the initial therapeutic decision of the physician
1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.
This study's enrollment of 851 is above the median of 174 across 446 observational studies indexed under Osteoporosis.
Browse Osteoporosis studies →251 Hellenic Air Force & VA General Hospital is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Female patients with postmenopausal osteoporosis
Male patients ≥ 50 years old with idiopathic osteoporosis
Male and female patients with steroid-induced osteoporosis
Exclusion Criteria:
The study will include patients from pre-defined groups of individuals (postmenopausal, male, and steroid-induced osteoporosis) who would any way receive teriparatide for their condition according to standard medical practice and Greek treatment guidelines
Also known as: osteo-anabolic treatment
Adherence to osteoporosis treatment assessed by medication possession ratio (MPR)
Adherence to osteoporosis treatment assessed by medication possession ratio Adherence to osteoporosis treatment assessed by medication possession ratio (MPR) and correlation with the parameters affecting the physicians' therapeutic choices
Time frame: 2 years
Quality of life assessed by EQ5D questionnaire
Quality of life assessed by EQ5D questionnaire and correlation with the parameters affecting the physicians' therapeutic choice
Time frame: 2 years
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
251 Hellenic Air Force & VA General Hospital